Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1501 Articles

Chris Lange | Apr 25, 2018 at 8:35 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Apr 17, 2018 at 11:35 AM EDT

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S.…

Chris Lange | Apr 11, 2018 at 1:25 PM EDT

Pfizer’s Kidney Drug Not Up to Par

Pfizer shares were relatively muted after the pharma giant provided an update for its late-stage kidney trial.

Chris Lange | Apr 11, 2018 at 8:30 AM EDT

The Major Pharma Stocks That Are Making Short Sellers Sick

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Apr 11, 2018 at 6:15 AM EDT

The 6 Most Shorted NYSE Stocks

Judging by the most shorted stocks traded on the New York Stock Exchange between the March 15 and March 29…

Chris Lange | Apr 2, 2018 at 1:20 PM EDT

Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage

Pfizer shares took a small step back on Monday despite announcing positive results from a late-stage trial. The pullback seems…

Chris Lange | Mar 27, 2018 at 8:45 AM EDT

Which Major Pharma Stocks Short Sellers Are Keen On

The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Mar 27, 2018 at 6:15 AM EDT

The 6 Most Shorted NYSE Stocks

Judging by the most shorted stocks traded on the New York Stock Exchange between the February 28 and March 15…

Paul Ausick | Mar 23, 2018 at 4:01 PM EDT

DowDuPont, 3M Sink the Dow Friday

DowDuPont, Goldman Sachs, 3M Company, and Pfizer pushed the Dow lower again Friday.

Chris Lange | Mar 23, 2018 at 10:25 AM EDT

Pfizer’s Chantix Study Goes Up in Smoke

Pfizer shares slipped slightly on Friday after the pharma giant announced results from its Chantix/Champix smoking cessation study in adolescents.

Chris Lange | Mar 12, 2018 at 8:35 AM EDT

Major Pharma Sees Big Drop in Short Interest

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Mar 12, 2018 at 7:00 AM EDT

GE and Intel Remain Short Sellers’ Favorite Dow Stocks

As of the most recently reported period, short sellers still favored just two Dow stocks, General Electric and Intel, above…

Paul Ausick | Mar 8, 2018 at 4:07 PM EST

The Dow Propped Up by Johnson & Johnson, Pfizer Thursday

The Dow wobbled around Thursday and looks set to close very near the break-even line as J&J, Pfizer, Caterpillar, and…

Chris Lange | Feb 28, 2018 at 9:10 AM EST

Short Sellers Hike Bets in Major Pharma

The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Feb 22, 2018 at 2:52 PM EST

Should Gilead Just Have Tried to Acquire Sangamo Rather Than a Collaboration Pact?

If the collaboration between Sangamo and Kite Pharma works out, some investors might just ask why Gilead did not just acquire Sangamo.

1 … 36 37 38 39 40 … 101

Pfizer : PFE

All Pfizer Articles

Short Sellers Grow More Selective on Major Pharma Stocks

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Pfizer’s Kidney Drug Not Up to Par

The Major Pharma Stocks That Are Making Short Sellers Sick

The 6 Most Shorted NYSE Stocks

Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage

Which Major Pharma Stocks Short Sellers Are Keen On

The 6 Most Shorted NYSE Stocks

DowDuPont, 3M Sink the Dow Friday

Pfizer’s Chantix Study Goes Up in Smoke

Major Pharma Sees Big Drop in Short Interest

GE and Intel Remain Short Sellers’ Favorite Dow Stocks

The Dow Propped Up by Johnson & Johnson, Pfizer Thursday

Short Sellers Hike Bets in Major Pharma

Should Gilead Just Have Tried to Acquire Sangamo Rather Than a Collaboration Pact?

Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Are DRAM Stocks Too Hot To Handle Yet or Is This Just the Start of a Bigger Move?

The Commercial Space Economy Just Crossed $500 Billion in Backlog and These 3 ETFs Own the Pure Play Names

FTEC vs. VGT: Same Tech Bet, So Which Fund Costs You Less?

Ford Is Calling Its 'Gray Beard' Engineers Back to Work. At 68, He Feared the Paycheck Would Cut His Social Security. Past Full Retirement Age, It Doesn't.

IRMAA Has Five Income Brackets. Crossing Just the First Costs You About $900 a Year.

Are DRAM Stocks Too Hot To Handle Yet or Is This Just the Start of a Bigger Move?

The Commercial Space Economy Just Crossed $500 Billion in Backlog and These 3 ETFs Own the Pure Play Names

Pfizer : PFE

All Pfizer Articles

Short Sellers Grow More Selective on Major Pharma Stocks

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Pfizer’s Kidney Drug Not Up to Par

The Major Pharma Stocks That Are Making Short Sellers Sick

The 6 Most Shorted NYSE Stocks

Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage

Which Major Pharma Stocks Short Sellers Are Keen On

The 6 Most Shorted NYSE Stocks

DowDuPont, 3M Sink the Dow Friday

Pfizer’s Chantix Study Goes Up in Smoke

Major Pharma Sees Big Drop in Short Interest

GE and Intel Remain Short Sellers’ Favorite Dow Stocks

The Dow Propped Up by Johnson & Johnson, Pfizer Thursday

Short Sellers Hike Bets in Major Pharma

Should Gilead Just Have Tried to Acquire Sangamo Rather Than a Collaboration Pact?

Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Are DRAM Stocks Too Hot To Handle Yet or Is This Just the Start of a Bigger Move?

The Commercial Space Economy Just Crossed $500 Billion in Backlog and These 3 ETFs Own the Pure Play Names

FTEC vs. VGT: Same Tech Bet, So Which Fund Costs You Less?

Featured Reads

Ford Is Calling Its 'Gray Beard' Engineers Back to Work. At 68, He Feared the Paycheck Would Cut His Social Security. Past Full Retirement Age, It Doesn't.

IRMAA Has Five Income Brackets. Crossing Just the First Costs You About $900 a Year.